Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal Cancer-Reference-Cited by-同舟云学术

Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal Cancer

Published:2022-03-29 Issue:3 Volume:5 Page:e224637
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Zhuo Na¹,Liu Chang¹,Zhang Qi¹,Li Jian¹,Zhang Xiaotian¹,Gong Jifang¹,Lu Ming¹,Peng Zhi¹,Zhou Jun¹,Wang Xicheng¹,Jiao Xi¹,Wang Yujiao¹,Wang Yanni¹,Gao Mengting¹,Shen Lin¹,Lu Zhihao¹

Affiliation:

1. Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, People’s Republic of China

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2790483/zhuo_2022_oi_220162_1647540229.9146.pdf

Reference28 articles.

1. PD-1/PD-L1 blockade therapy in advanced non-small-cell lung cancer: current status and future directions.;Xia;Oncologist,2019

2. Current status and future perspective of immunotherapy in gastrointestinal cancers.;Lu;Innovation (N Y),2020

3. Human anti-tumor immunity: insights from immunotherapy clinical trials.;Egen;Immunity,2020

4. Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer.;Kojima;J Clin Oncol,2020

5. CheckMate 649: a randomized, multicenter, open-label, phase III study of nivolumab (NIVO) + ipilimumab (IPI) or nivo + chemotherapy (CTX) versus CTX alone in patients with previously untreated advanced (Adv) gastric (G) or gastroesophageal junction (GEJ) cancer;Moehler;J Clin Oncol,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fecal microbiota transplantation promotes immunotherapy sensitivity in refractory gastrointestinal cancer patients: open label, single-arm, single center, phase 1 study;2024-08-21

2. Recent developments in immunotherapy for gastrointestinal tract cancers;Journal of Hematology & Oncology;2024-08-09

3. Rechallenge with immune checkpoint inhibitors for advanced esophageal squamous cell carcinoma;International Immunopharmacology;2024-08

4. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy;Cancers;2024-05-24

5. The rising roles of exosomes in the tumor microenvironment reprogramming and cancer immunotherapy;MedComm;2024-04